- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Saccharomyces boulardii gets not destroyed by gastric acid and is not absorbed.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Acute diarrhea |
|---|
|
| Prophylaxis of diarrhea |
|---|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Patients suffering diarrhea, especially children, should consider replacing fluids and salts (electrolytes) as the most important treatment option.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Ardeypharm, SmPC Yomogi Kps. (1-23695), 01/2018
- Szajewska H, et al, Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update. 2020 , J Pediatr Gastroenterol Nutr. , 2020, Aug;71(2), 261-9
- Szajewska H, et al., Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children., J Pediatr Gastroenterol Nutr., 2016, MAr;62(3), 495-506
- Ardeypharm GmbH, SmPC Yomogi 250 mg (89086.00.00), 12/2017
- Szajewska H, et al, Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update. 2020, J Pediatr Gastroenterol Nutr., 2020, Aug;71(2), 261-9
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
